From a global point of view, the developing of big data management and the human genome project from recent decades, may affect our perspective of management. Healthcare will become more precise to individuals.
This book is highly recommend for concerned readers who choose to continue education in the dynamic era of precision medicine. Kristin based her findings on her experience for over 20 years, including drug pipeline research to uncover both current and future therapeutic drugs and diagnostic tools.
From her experience her potential readers are researchers, physicians, oncologists, pharmaceutical companies, patients and caregivers who are interested in understanding precision medicine from vision to reality.